Casi pharmaceuticals announces first quarter 2025 business and financial results

Beijing, cn / access newswire / may 16, 2025 / casi pharmaceuticals, inc. (nasdaq:casi), ("casi" or the "company"), a cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the quarter ended march 31, 2025. dr. wei-wu he, ph.d.
CASI Ratings Summary
CASI Quant Ranking